• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

    41.74 -2.48 (-5.60%)
    Streaming Delayed Price Updated: 11:42 AM EST, Feb 27, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 231,167
    Open 43.50
    Bid (Size) 41.70 (200)
    Ask (Size) 41.79 (100)
    Prev. Close 44.22
    Today's Range 41.67 - 44.05
    52wk Range 23.23 - 50.79
    Shares Outstanding 32,250,236
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Collegium (COLL) Q4 2025 Earnings Call Transcript ↗
    Collegium (COLL) Q4 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings
    Collegium Pharmaceutical Inc (NASDAQ:COLL) Reports Q4 Revenue Growth but Misses Earnings Estimates ↗
    Via Chartmill

    Performance

    YTD
    -8.3%
    -8.3%
    1 Month
    -7.9%
    -7.9%
    3 Month
    -10.6%
    -10.6%
    6 Month
    +8.9%
    +8.9%
    1 Year
    +47.2%
    +47.2%

    More News

    Read More
    News headline image
    Collegium Pharmaceutical’s (NASDAQ:COLL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations
    Via StockStory
    News headline image
    Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    COLLEGIUM PHARMACEUTICAL INC (NASDAQ:COLL) Presents a Classic Value Case with High Earnings and Low Valuation ↗
    Via Chartmill
    Collegium Pharmaceutical Inc (NASDAQ:COLL) Presents a Compelling Value Investment Case ↗
    Via Chartmill
    News headline image
    Collegium Pharmaceutical (COLL) Q4 Earnings: What To Expect
    Via StockStory
    Topics World Trade
    News headline image
    Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium to Report Fourth Quarter and Full-Year 2025 Financial Results on February 26, 2026
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    1 Profitable Stock on Our Watchlist and 2 That Underwhelm
    Via StockStory
    News headline image
    Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium Pharmaceutical EVP Sells COLL 17,600 Shares Amid Strong Close of 2025 ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    3 Small-Cap Stocks We’re Skeptical Of
    Via StockStory
    News headline image
    Collegium Provides 2026 Financial Guidance and Business Update
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    3 Russell 2000 Stocks Walking a Fine Line
    Via StockStory
    News headline image
    Collegium Announces the Closing of $980 Million Syndicated Credit Facility
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    2 Reasons to Avoid COLL and 1 Stock to Buy Instead
    Via StockStory
    Topics Supply Chain
    News headline image
    3 Cash-Producing Stocks We Think Twice About
    Via StockStory
    News headline image
    Collegium Pharmaceutical Inc (NASDAQ:COLL) Shows Strong Earnings Momentum and Bullish Technical Setup ↗
    Via Chartmill
    News headline image
    3 Unpopular Stocks We Find Risky
    Via StockStory
    News headline image
    Collegium Pharmaceutical Inc (NASDAQ:COLL) Fits the Minervini Growth Momentum Strategy ↗
    Via Chartmill
    News headline image
    Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL)
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    1 Growth Stock Set to Flourishand 2 Facing Challenges
    Via StockStory
    News headline image
    1 Mooning Stock with Promising Prospects and 2 Facing Challenges
    Via StockStory
    News headline image
    1 Small-Cap Stock with Exciting Potential and 2 We Avoid
    Via StockStory

    Frequently Asked Questions

    Is Collegium Pharmaceutical, Inc. - Common Stock publicly traded?
    Yes, Collegium Pharmaceutical, Inc. - Common Stock is publicly traded.
    What exchange does Collegium Pharmaceutical, Inc. - Common Stock trade on?
    Collegium Pharmaceutical, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock?
    The ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock is COLL on the Nasdaq Stock Market
    What is the current price of Collegium Pharmaceutical, Inc. - Common Stock?
    The current price of Collegium Pharmaceutical, Inc. - Common Stock is 41.74
    When was Collegium Pharmaceutical, Inc. - Common Stock last traded?
    The last trade of Collegium Pharmaceutical, Inc. - Common Stock was at 02/27/26 11:42 AM ET
    What is the market capitalization of Collegium Pharmaceutical, Inc. - Common Stock?
    The market capitalization of Collegium Pharmaceutical, Inc. - Common Stock is 1.35B
    How many shares of Collegium Pharmaceutical, Inc. - Common Stock are outstanding?
    Collegium Pharmaceutical, Inc. - Common Stock has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.